18 and older, any sex, with Hearing Loss, Sensorineural. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Speech Intelligibility (Percent Correct Scores)Primary· ~20 mins for each intervention over the course of 1-2 days
Listeners will listen to and repeat recorded low-context sentences mixed with noise from different spatial locations. Speech intelligibility will be measured immediately following hearing aid fitting. Scoring is determined by percentage of words repeated correctly. Scores range from 0-100% (higher score indicates better performance). This task may take up to 1-2 visits (\~ 2 hours each) for different combinations of hearing aid features. The device will only be worn in the laboratory for the duration of the experimental task and will be retrieved by the investigator at the end of each visit.
Group
Value
95% CI
Setting 1
0.55
0.52 – 0.57
Setting 2
0.59
0.56 – 0.62
Setting 3
0.70
0.67 – 0.73
Setting 4
0.80
0.78 – 0.82
Sponsor's own description
The goal of this project is to determine whether the selection of hearing aid settings should be based in part on an individual's cognitive characteristics (specifically, working memory). We anticipate the outcomes of this study to be applicable to realistic listening conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT06167161 — Clinical Investigation and Validation of a Self-fitted Air-conduction Hearing Aid
· NA
· completed
NCT05197803 — Clinical Study of Released Unitron RIC and BTE Hearing Aid Models
· NA
· completed
NCT04875117 — Fatigue and Hearing Loss.
· completed
NCT03316287 — Big Data Supporting Public Health Hearing Policies
· NA
· completed
NCT02269124 — Use of Amplification in Children With Unilateral Hearing Loss
· NA
· completed
Other recruiting trials for Hearing Loss, Sensorineural
Currently open trials in the same condition.
NCT06499805 — Barriers and Facilitators to OTC Hearing Aids Success
· NA
· recruiting
NCT06560918 — Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids
· NA
· recruiting
NCT06882889 — Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL
· NA
· recruiting
NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System
· recruiting
NCT06268340 — Hearing and Structure Preservation Via ECochG
· NA
· recruiting
Other Northwestern University trials
Trials by the same sponsor.
NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies
· Phase 1, PHASE2
· not yet recruiting
NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C
· EARLY_PHASE1
· not yet recruiting
NCT07392775 — ALDH2 Genetic Testing in East Asian Community
· NA
· not yet recruiting
NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill
· NA
· not yet recruiting
NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwestern University
Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04521166.